Treatment with CSF1R inhibitor GW2580 or PLX5622 significantly reduced the severity, and prevented the progression of MS in an experimental allergic encephalomyelitis (EAE) animal model (Borjini et al., 2016; Nissen et al., 2018). Here, CSF1R is linked to myeloid sarcoma.